EUDAXEN 50 MG/*54745756836*/
EUDAXEN 50 MG
Categories: Anti-Diabetic, BEST SELLER, Bladder Cancer, Breast Cancer, Diabetic, Endometrial Cancer, Leukaemia, Lymphoma, ONCOLOGY PRODUCTS, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer
Tags: ALECNIB, BARICINIX 4 MG, Baricitinib, Beacon Pharmaceuticals Ltd., Cancer Medicine in Bangladesh, EUDAXEN, EUDAXEN 50 MG, Oncology Medicine Supplier, Oncology Medicine Supplier in Bangladesh, Oncology Medicines
Reviews (0)
Be the first to review “EUDAXEN 50 MG” Cancel reply
Shipping & Delivery
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing/*54745756836*/
Related products
CABOZANIX 20 MG
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
JUPARIB 150 MG
Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd. Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy
AXINIX 1 MG
Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior
BARICINIX 4 MG
Product Description: Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded
Elbonix 50
COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL
DACLAXEN 60 MG
Indications Daclatasvir is indicated in combination with Sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection in adults.
CABOZANIX 80 MG
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
AXINIX 5 MG
DESCRIPTION Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one
Reviews
There are no reviews yet.